| J9271 | Injection, pembrolizumab, 1 mg | 14,900 | $40 | $640.7K |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 300 | $270 | $81.8K |
| J0897 | Injection, denosumab, 1 mg | 3,120 | $20 | $56.2K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 560 | $80 | $45.1K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 430 | $100 | $42.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 450 | $90 | $41.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 610 | $60 | $36.7K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 7,250 | $1 | $14.5K |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 630 | $20 | $13.8K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 1,580 | $10 | $12.7K |